Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes
International Journal of Radiation Oncology*Biology*Physics · 2023-11 · 117 (4) · 869-882
DOI: 10.1016/j.ijrobp.2023.02.023 ↗Kurz gefasst
Metaanalyse in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2023-11. Verfasst von Francesca Holt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. Electronic address: francesca.holt@ndph.ox.ac.uk. Hauptthemen laut MEDLINE: Breast Neoplasms, Proton Therapy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
PURPOSE: Adjuvant proton beam therapy (PBT) is increasingly available to patients with breast cancer. It achieves better planned dose distributions than standard photon radiation therapy and therefore may reduce the risks. However, clinical evidence is lacking. METHODS AND MATERIALS: A systematic review of clinical outcomes from studies of adjuvant PBT for early breast cancer published in 2000 to 2022 was undertaken. Early breast cancer was defined as when all detected invasive cancer cells are in the breast or nearby lymph nodes and can be removed surgically. Adverse outcomes were summarized quantitatively, and the prevalence of the most common ones were estimated using meta-analysis. RESULTS: Thirty-two studies (1452 patients) reported clinical outcomes after adjuvant PBT for early breast cancer. Median follow-up ranged from 2 to 59 months. There were no published randomized trials comparing PBT with photon radiation therapy. Scattering PBT was delivered in 7 studies (258 patients) starting 2003 to 2015 and scanning PBT in 22 studies (1041 patients) starting 2000 to 2019. Two studies (123 patients) starting 2011 used both PBT types. For 1 study (30 patients), PBT type was unspecified. Adverse events were less severe after scanning than after scattering PBT. They also varied by clinical target. For partial breast PBT, 498 adverse events were reported (8 studies, 358 patients). None were categorized as severe after scanning PBT. For whole breast or chest wall ± regional lymph nodes PBT, 1344 adverse events were reported (19 studies, 933 patients). After scanning PBT, 4% (44/1026) of events were severe. The most prevalent severe outcome after scanning PBT was dermatitis, which occurred in 5.7% (95% confidence interval, 4.2-7.6) of patients. Other severe adverse outcomes included infection, pain, and pneumonitis (each ≤1%). Of the 141 reconstruction events reported (13 studies, 459 patients), the most prevalent after scanning PBT was prosthetic implant removal (34/181, 19%). CONCLUSIONS: This is a quantitative summary of all published clinical outcomes after adjuvant PBT for early breast cancer. Ongoing randomized trials will provide information on its longer-term safety compared with standard photon radiation therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. Electronic address: francesca.holt@ndph.ox.ac.uk.
- Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
- Centre for Evaluation and Methods, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
- Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
- Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, United Kingdom.
- Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; Department of Medical Physics, Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom.
Förderung
- Cancer Research UK
Zitieren
APA
Holt, F., Probert, J., Darby, S. C., Haviland, J. S., Coles, C. E., Kirby, A. M., Liu, Z., Dodwell, D., Ntentas, G., Duane, F., & Taylor, C. (2023). Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes. International Journal of Radiation Oncology*Biology*Physics, 117(4), 869-882. https://doi.org/10.1016/j.ijrobp.2023.02.023
Vancouver
Holt F, Probert J, Darby SC, Haviland JS, Coles CE, Kirby AM, et al. Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes. International Journal of Radiation Oncology*Biology*Physics. 2023;117(4):869-882. doi:10.1016/j.ijrobp.2023.02.023
BibTeX
@article{Holt2023,
author = {Holt, Francesca and Probert, Jake and Darby, Sarah C and Haviland, Joanne S and Coles, Charlotte E and Kirby, Anna M and Liu, Zulian and Dodwell, David and Ntentas, Georgios and Duane, Frances and Taylor, Carolyn},
title = {Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2023},
volume = {117},
number = {4},
pages = {869--882},
doi = {10.1016/j.ijrobp.2023.02.023}
}
EUVIMED